x

Pesquisar um ensaio clínico

* (*) campo(s) de preenchimento obrigatório

32 Resultado(s)

Ordenados por

Ensaio em fase de recrutamento = Ensaio em fase de recrutamento; Ensaio a decorrer = Ensaio a decorrer; Financiado por um membro do IRDiRC =

Ensaio (s) clínico (s) nacional (is)

FRANCA

ILE-DE-FRANCE
PARIS

MAINRISTAN: MAINtenance of Remission Using RITuximab in Systemic ANCA-associated Vasculitis (Phase III)
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCA

ILE-DE-FRANCE
PARIS

IMPROVE: International mycophenolate mofetil protocol to reduce out breaks of vasculitis (Phase III)
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCA

ILE-DE-FRANCE
PARIS

CORTAGE : Treatment of necrotizing vasculitis in elderly (65 years old and over) (Phase IV)
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

PAISES BAIXOS

Groningen
GRONINGEN

PAISES BAIXOS

Groningen
GRONINGEN

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
UMCG - Universitair Medisch Centrum Groningen
Afdeling Reumatologie & Klinische Immunologie

FRANCA

ILE-DE-FRANCE
PARIS

RATTRAP : Infliximab versus rituximab in systemic necrosing vascularizes with positive ANCA after relapse or resistant immunosuppressant therapies (Phase III) - Terminated -
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio a decorrerPEXIVAS: Plasma Exchange and Glucocorticoid Dosing in the Treatment of Anti-neutrophil Cytoplasm Antibody Associated Vasculitis. An International Randomised Controlled Trial (phase III) - FR
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

REINO UNIDO

Greater London
LONDON

ABAVAS: Abatacept in ANCA associated vasculitis (phase II-III)
Hammersmith Hospital
Renal Section, Division of Medicine

REINO UNIDO

Lothian
EDINBURGH

Ensaio em fase de recrutamentoEnsaio a decorrerThe Vascular Effects of Endothelin Receptor Antagonism in Systemic Vasculitis
School of Informatics, The University of Edinburgh
University of Edinburgh

REINO UNIDO

Cambridgeshire
CAMBRIDGE

REINO UNIDO

Greater London
LONDON

Ensaio (s) clínico (s) multinacional (ais)